| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 |
|---|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities | |||||||||
Net loss | |||||||||
-4,183 | 1,727 | -3,306 | -6,476 | -51,465 | -30,532 | -17,965 | -3,857 | 19 | - |
Net loss | |||||||||
- | - | - | - | - | - | - | - | - | -7,736 |
Adjustments to reconcile net loss to net cash used in operating activities: | |||||||||
Amortization of patent portfolio | |||||||||
- | 1,405 | 1,373 | 2,135 | 6,317 | 9,831 | 267 | 0 | - | - |
Change in fair value of investment | |||||||||
1,406 | 8,194 | 345 | 0 | - | - | - | - | - | - |
Non-cash registration rights penalty | |||||||||
- | - | - | - | - | 654 | 0 | - | - | - |
Change in fair value of warrant liabilities | |||||||||
82 | 740 | -120 | 2,257 | 269 | 48 | 2,618 | - | - | - |
Research and development-acquired license, expensed | |||||||||
2,512 | - | - | - | - | - | - | - | - | - |
Gain on settlement of obligations | |||||||||
- | - | - | - | - | - | - | - | -845 | - |
Depreciation and amortization | |||||||||
- | - | - | - | - | - | - | - | 66 | 77 |
Stock-based compensation | |||||||||
329 | 320 | 23 | 562 | 371 | 12,676 | 9,971 | 56 | 35 | 37 |
Issuance of common stock - financial advisor | |||||||||
- | - | - | - | - | -225 | - | - | - | - |
Fair value adjustments for warrant liabilities | |||||||||
- | - | - | - | - | - | - | -1,202 | - | - |
Loss on issuance of warrants | |||||||||
- | - | - | - | - | - | - | 622 | 4 | - |
Depreciation expense | |||||||||
- | 38 | 3 | 3 | 1 | 0 | 24 | 64 | - | - |
Realized loss on marketable securities | |||||||||
-172 | -400 | -328 | -95 | 0 | - | - | - | - | - |
Unrealized loss (gain) on marketable securities | |||||||||
145 | -117 | 240 | -243 | 19 | -54 | 0 | - | - | - |
Impairment of intangible assets | |||||||||
- | - | - | 2,713 | 40,600 | 0 | - | - | - | - |
Impairment of intangible assets | |||||||||
- | 2,173 | - | - | - | - | - | - | - | - |
Provision for doubtful accounts | |||||||||
- | - | - | - | - | - | - | -8 | 8 | - |
Changes in assets and liabilities: | |||||||||
Marketable securities | |||||||||
- | - | - | - | - | 3,554 | 0 | - | - | - |
Other receivables | |||||||||
- | - | - | - | - | - | 2 | 5 | 262 | 269 |
Prepaid expenses and other assets | |||||||||
-7 | 38 | 15 | -195 | 223 | -44 | -14 | 236 | 289 | 410 |
Deposit | |||||||||
- | - | - | - | - | - | - | 0 | - | - |
Accounts payable and accrued expenses | |||||||||
-64 | 74 | -67 | -261 | -344 | 458 | -158 | 193 | -366 | -327 |
Accrued salaries and benefits | |||||||||
-50 | 37 | 249 | -199 | 316 | 96 | -52 | 0 | - | - |
Payable to DatChat | |||||||||
107 | - | - | - | - | - | - | - | - | - |
Deferred revenue | |||||||||
- | - | -1,216 | 3,497 | 268 | 0 | -45 | -3 | -33 | -28 |
Accrued lease liabilities | |||||||||
- | -48 | -179 | -180 | -173 | 580 | 0 | - | - | - |
Purchase of patent portfolio | |||||||||
- | - | - | - | - | - | 2,000 | 0 | - | - |
Net cash used in operating activities | |||||||||
-3,017 | -2,729 | -3,272 | 70 | - | - | - | - | - | -8,693 |
Cash flows from investing activities | |||||||||
Deferred compensation | |||||||||
- | - | - | - | - | - | - | - | -305 | -30 |
Net cash used in activities of continuing operations | |||||||||
- | - | - | - | - | - | -5,352 | -3,648 | -4,349 | - |
Net cash provided by (used in) activities of discontinued operations | |||||||||
- | - | - | - | - | - | 86 | -167 | -10 | -5 |
Net cash (used in) provided by operating activities | |||||||||
- | - | - | - | -4,620 | -9,516 | -5,266 | -3,815 | -4,359 | -8,687 |
Purchase of marketable securities | |||||||||
8,461 | 14,280 | 12,274 | 18,035 | 7,994 | 0 | - | - | - | - |
Cash acquired in acquisition of North South | |||||||||
- | - | - | - | - | - | 2,662 | 0 | - | - |
Security deposits collected | |||||||||
- | - | - | - | - | - | 4 | - | - | - |
Security deposits refund | |||||||||
- | - | - | - | - | 4 | 0 | - | - | - |
Sale of marketable securities | |||||||||
10,277 | 15,061 | 14,213 | 15,065 | 8,121 | 0 | - | - | - | - |
Purchase of investments at fair value | |||||||||
200 | 922 | 675 | - | - | - | - | - | - | - |
Release of deposit | |||||||||
- | -26 | - | - | - | - | - | - | - | - |
Purchase of research and development licenses | |||||||||
360 | - | - | - | - | - | - | - | - | - |
Purchase of property and equipment | |||||||||
- | 36 | - | 4 | 2 | 4 | 0 | 2 | 2 | - |
Investment in Hoth Therapeutics, Inc. | |||||||||
- | - | - | 0 | - | - | - | - | - | - |
Payment of accrued patent costs | |||||||||
- | - | - | - | - | 1,000 | 0 | - | - | - |
Net cash provided by activities of discontinued operations | |||||||||
- | - | - | - | - | - | - | 4 | -2 | - |
Net cash (used in) provided by investing activities | |||||||||
1,256 | -151 | 1,264 | -2,974 | 125 | -1,000 | 658 | 2 | -4 | 375 |
Proceeds from issuance of note payable | |||||||||
- | - | - | - | - | - | 500 | 0 | - | - |
Proceeds from issuance of common stock and preferred stock in December Offering, net | |||||||||
- | - | - | - | 3,445 | 0 | 2,425 | - | - | - |
Cash paid for cancellation of fractional shares of common stock | |||||||||
- | - | - | - | 0 | - | - | - | - | - |
Cash flows from financing activities | |||||||||
Net cash provided by (used in) investing activities | |||||||||
- | - | - | - | - | - | - | -2 | -2 | 375 |
Cash paid for cancellation of common stock | |||||||||
- | - | - | 4 | - | - | - | - | - | - |
Proceeds from issuance common stock, net of offering cost | |||||||||
787 | 2,700 | 2,095 | 2,140 | 0 | - | - | - | 4,034 | - |
Proceeds from issuance common stock/ At-the-market offering | |||||||||
1,154 | - | - | - | - | - | - | - | - | - |
Offering costs fro the issuance of common stock / At-the-market offering | |||||||||
-106 | - | - | - | - | - | - | - | - | - |
Proceeds from issuance of common stock and warrants in July Financing, net | |||||||||
- | - | - | - | 1,322 | 0 | 310 | - | - | - |
Proceeds from exercise of warrants | |||||||||
- | - | - | 760 | - | - | - | - | - | - |
Repurchase of restricted stock units to pay for employee withholding taxes | |||||||||
- | - | 24 | 0 | - | - | - | - | - | - |
Other Income from Change in Fair Value of Warrants | |||||||||
- | - | - | - | - | - | - | - | -3,716 | - |
Proceeds from exercise of warrants | |||||||||
- | - | - | - | 0 | - | - | 246 | 230 | - |
Issuance of Series E preferred stock for cash, net | |||||||||
- | - | - | - | - | - | - | 0 | - | - |
Issuance of Series F preferred stock for cash, net | |||||||||
- | - | - | - | - | - | - | 0 | - | - |
Proceeds from issuance of common stock and warrants in private placement, net | |||||||||
- | - | - | - | - | 3,874 | - | 3,402 | - | - |
Proceeds from issuance of Series J convertible preferred stock, net | |||||||||
- | - | - | - | - | 18,387 | - | - | - | - |
Redemption of Series I redeemable convertible preferred stock | |||||||||
- | - | - | - | 935 | 14,065 | 0 | - | - | - |
Net cash provided by financing activities | |||||||||
1,835 | 2,700 | 2,071 | 2,896 | 3,832 | 8,196 | 3,235 | 3,400 | 3,700 | 4,867 |
Reverse stock split fractional share payment | |||||||||
- | - | - | - | - | - | - | 2 | - | - |
Issuance cost of common stock and warrants | |||||||||
- | - | - | - | - | - | - | - | -333 | - |
Reverse stock split fractional shares payment | |||||||||
- | - | - | - | - | - | - | - | 0 | - |
Net cash (used in) provided byfinancing activities | |||||||||
- | - | - | - | - | - | - | 3,400 | 3,700 | 4,867 |
Net increase in cash and cash equivalents | |||||||||
74 | -180 | 63 | -8 | -663 | -2,320 | -1,373 | -413 | -663 | - |
Cash paid for interest and taxes | |||||||||
- | - | 195 | 0 | 0 | 0 | 0 | - | 160 | - |
Prepaid expenses | |||||||||
- | - | - | - | - | - | - | 0 | - | - |
Patent portfolio | |||||||||
- | - | - | - | - | - | - | 0 | - | - |
Goodwill | |||||||||
- | - | - | - | - | - | - | 0 | - | - |
Common and preferred stock issued | |||||||||
- | - | - | - | - | - | - | 0 | - | - |
Cash Acquired in acquisition of North South | |||||||||
- | - | - | - | - | - | - | 0 | - | - |
Issuance of common and preferred stock for Rockstar patents | |||||||||
- | - | - | - | - | - | - | 0 | - | - |
Non-cash investing and financing activities | |||||||||
Investment in DatChat | |||||||||
- | 207 | - | - | - | - | - | - | - | - |
Investment in Mellow Scooters | |||||||||
- | 2 | - | - | - | - | - | - | - | - |
Distribution of Hoth common stock | |||||||||
1,698 | - | - | - | - | - | - | - | - | - |
Extinguishment of Series H Convertible Preferred Stock in connection with license agreement | |||||||||
- | - | - | 31,480 | 4,766 | 0 | - | - | - | - |
Recognition of deferred revenue in connection with license agreement | |||||||||
- | - | - | - | 281 | 0 | - | - | - | - |
Retirement of treasury stock | |||||||||
- | - | - | - | - | 201 | 0 | - | - | - |
Conversion of preferred stock to common stock | |||||||||
- | - | - | - | - | 3 | 0 | - | - | - |
Extinguishment of Series I Convertible Preferred Stock in connection with license agreement | |||||||||
- | - | - | - | 5,000 | 0 | - | - | - | - |
Recognition of deferred revenue in connection with license agreement | |||||||||
- | - | - | 414 | - | - | - | - | - | - |
Issuance of Series C Convertible Preferred Stock in connection with exchange of warrants | |||||||||
- | - | - | - | - | - | 5,696 | 0 | - | - |
Issuance of common and preferred stock for Rockstar patents | |||||||||
- | - | - | - | - | - | 61,000 | - | - | - |
Accrued Rockstar patent cost | |||||||||
- | - | - | - | - | - | 1,000 | - | - | - |
Accrued Rockstar patent cost | |||||||||
- | - | - | - | - | - | - | 0 | - | - |
Retirement of Series E Convertible Preferred STock | |||||||||
- | - | - | - | - | - | 500 | 0 | - | - |